OGN

Organon & Co.

Halal Rating :
Uncomfortable
Last Price $15.75 Last updated:
Market Cap $4.05b
7D Change 0.57%
1 Year Change 0.38%
Company Overview Use of Interest Company Impact Justification for our Halal Rating Recent News

Company Overview

Industries
  • Manufacturing
  • Pharmaceutical Products
  • Pharmaceutical Preparations
Exchange NYSE
Next Earnings Date Oct. 31, 2024

Organon & Co. is a global healthcare company focused on women's health. The company develops and produces medicines, biosimilars, and established branded products in three primary areas: women's health, biosimilars, and established brands. Their portfolio includes contraceptive and fertility brands, hormone therapy, and other medications.

Use of Interest

Reporting Date Total Revenue Total Operating Expense Interest Income Interest Expense Interest Income Ratio Interest Expense Ratio
Sept. 30, 2024 $1.58b $1.37b - $126.0m 0.00% 9.20%
June 30, 2024 $1.61b $1.37b - $131.0m 0.00% 9.58%
March 31, 2024 $1.62b $1.38b - $131.0m 0.00% 9.51%

Company Impact

Help us evaluate Organon & Co.'s impact from a halal perspective. Vote on the most significant aspect and submit any considerations that we may have missed.

Contribute

Recent News & Updates